Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Trulieve Was the First U.S. Pure-Play Cannabis Stock on the NYSE. Here's Which Stock Could Be Next.

Key PointsTrulieve became the first U.S. cannabis operator listed on the NYSE.

Trulieve Cannabis made history as the first U.S. pure-play cannabis company to list on the New York Stock Exchange (NYSE) on June 10, marking a significant milestone for the industry. This achievement came after a major shift in federal marijuana policy, where the April 2026 decision moved state-licensed medical marijuana into Schedule III, opening doors for therapeutic drugs to trade on major exchanges. Trulieve's success prompted speculation about which other cannabis companies might follow suit.

Green Thumb Industries (GTBIF), one of the largest cannabis operators in the country, is a potential candidate for a major NYSE listing. The company boasts impressive financial metrics, including $324.4 million in revenue, an 11% year-over-year increase, and normalized EBITDA of $89.4 million, representing a 27.6% margin. Moreover, Green Thumb generated $58.3 million in operating cash flow and holds $316 million in cash reserves, demonstrating financial stability.

However, Green Thumb faces regulatory challenges and hasn't announced an uplisting plan. Unlike Trulieve, which operates solely in the medical cannabis market post-structure, Green Thumb continues to serve both recreational and medical customers, complicating its path to a regulated listing. Despite these hurdles, the company has been returning capital to shareholders through a stock repurchase program, buying back about 29.5 million shares at a cost of $203.4 million since 2023.

If federal cannabis reforms continue and major exchanges become more accessible to U.S. operators, Green Thumb's robust financials position it as a credible contender to follow Trulieve into the NYSE. While an official listing date remains undetermined, Green Thumb's profile, financial strength, and strategic position make it a compelling candidate for the next cannabis stock to be listed on Wall Street.

Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at nasdaq.com →

More in Finance & Markets

Citadel hires Hartree options chief as commodities trading partner

Citadel has appointed former Hartree Partners global head of commodities options trading Thomas Lefebvre as a partner and portfolio manager for global volatility trading in London, strengthening its…

  • Citadel hires Thomas Lefebvre from Hartree Partners
  • Lefebvre heads global commodities options trading
  • Strengthened Citadel's volatility trading capabilities

Family offices cut hedge fund exposure as equity allocations rise

Family offices increased their allocations to public equities during the third quarter while reducing exposure to hedge funds and other alternative investments, as wealthy investors sought to maintain…

  • Family offices increased equity allocations to 36.4% in Q3.
  • Hedge fund exposure reduced to 7.5% due to market volatility.
  • Real estate investments declined to 7.2% amid rising interest rates.

More from Friday 20 November →